Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Dewpoint Therapeutics

News headline image
Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer
From Dewpoint Therapeutics
Via GlobeNewswire
News headline image
Dewpoint Therapeutics Announces TDP-43 Condensate Modulator Development Candidate for Treatment of ALS and Related Neurodegenerative Diseases
From Dewpoint Therapeutics
Via GlobeNewswire
News headline image
Dewpoint Therapeutics Launches Initiative to Build Viral Condensate Phenomics Atlas for HPV
From Dewpoint Therapeutics
Via GlobeNewswire
News headline image
FDA Grants Fast Track Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer
From Dewpoint Therapeutics
Via GlobeNewswire
News headline image
FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer
From Dewpoint Therapeutics
Via GlobeNewswire
News headline image
Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers
From Dewpoint Therapeutics
Via GlobeNewswire
News headline image
Dewpoint Therapeutics Announces Presentation at AACR-NCI-EORTC 2025
From Dewpoint Therapeutics
Via GlobeNewswire
News headline image
Dewpoint Therapeutics Closes Series D Financing to Advance First-in-Class Condensate Modulator (c-mod) into Clinical Development for Gastric Cancer
From Dewpoint Therapeutics
Via GlobeNewswire
News headline image
Dewpoint Therapeutics announces upcoming presentations at AACR 2025
From Dewpoint Therapeutics
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.